A review published in the International Journal of Molecular Science offers a “unified model” for using key biomarkers to inform biologic treatment strategies in patients with severe eosinophilic asthma. “[Severe asthma (SA)] is...
Read More
Researchers reported significant clinical improvements following the use of monoclonal antibodies in patients with severe asthma exacerbations.
Read More
Interleukin 15 expression in asthmatic airways negatively correlated with lung function, a finding that improves understanding of asthma heterogeneity.
Read More
Regardless of the presence of nasal polyps and aeroallergen sensitivity, patients with severe eosinophilic asthma can benefit from treatment with mepolizumab.
Read MoreIn various healthcare settings, healthcare professionals dedicate themselves to delivering quality patient care, sometimes ignoring their own selfcare needs. Several studies have also shown that the pandemic has highlighted...
Read More
